Medicinal Chemistry Research

, Volume 24, Issue 4, pp 1662–1671 | Cite as

Amino- and fluoro-substituted quinoline-4-carboxylic acid derivatives: MWI synthesis, cytotoxic activity, apoptotic DNA fragmentation and molecular docking studies

  • Hardik G. BhattEmail author
  • Yadvendra K. Agrawal
  • Manish J. Patel
Original Research


In continuation of our research work on amino substituted quinoline-4-carboxylic acid derivatives, microwave irradiated and conventional heating methods were used for synthesis of target compounds. Benzaldehyde, pyruvic acid, and 3-chloro-4-fluoroaniline in absolute ethanol media reacted, condensed, and cyclized to form intermediate 7-chloro-6-fluoro-2-phenyl-quinoline-4-carboxylic acid. This intermediate reacted with various substituted amines attaining desired products 6-fluoro-2-phenyl-7-substitutedamino-quinoline-4-carboxylic acid derivatives (7a–7l). Products obtained by microwave synthesizer showed short reaction time of 110–210 s and yield of 91–96 %, demonstrating advantages of the said method. All synthesized compounds were identified and characterized by FT-IR, 1H and 13C NMR, Mass spectroscopy, and Elemental analysis. Synthesized compounds were tested for their effect on cellular viability against various carcinoma cell lines viz. MCF-7, HELA, Hep-2, NCI, HEK-293, and VERO by XTT bioassay at 24 h of drug exposure using doxorubicin and methotrexate as standard drugs. Majority of the compounds proved to be more potent than doxorubicin and compounds 7a, 7c, 7d, and 7i exhibited significant anticancer activity. Apoptotic DNA fragmentation was carried out on MCF-7 and HEK-293 cell lines and found that few compounds exhibited excellent DNA fragmentation pattern confirming apoptosis. Docking study was performed by Surflexdock to establish probable mechanism of action of synthesized compounds using X-ray crystallographic structure of the ATPase domain of hTopoIIα. Docking experiments confirmed good correlation between calculated interactions with the hTopoIIα and the observed IC50 values. The present study of quinoline-4-carboxylic acid derivatives may be considered as promising lead for future design of potent hTopoIIα inhibitors as novel anticancer agents.


Quinoline-4-carboxylic acid Microwave irradiation Cytotoxic activity Apoptosis hTopoIIα Molecular docking 



H. G. Bhatt is thankful to Nirma University, Ahmedabad, India for providing necessary facilities to carry out the research work.


  1. Asahina Y, Takei M (2012) 7-(4-substituted-3-cyclopropyl-aminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivatives. US Patent 8,106,072Google Scholar
  2. Atwell GJ, Baguley BC, Denny WA (1989) Potential antitumor agents.57.2-phenylquinoline -8-carboxamides as “minimal” DNA-intercalating antitumor agents with in vivo solid tumor activity. J Med Chem 32:396–401CrossRefPubMedGoogle Scholar
  3. Batt DG, Petraitis JJ, Sherk SR (1996) 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents. US Patent 5,578,609Google Scholar
  4. Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV (2011) N-Fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. J Med Chem 54:5013–5030CrossRefPubMedGoogle Scholar
  5. Bhatt HG, Agrawal YK (2010) Microwave irradiated synthesis and antimicrobial activity of 2-phenyl-7-substitutedalkyl/arylaminoquinoline-4-carboxylic acid derivatives. Med Chem Res 19:392–402CrossRefGoogle Scholar
  6. Castelli S, Katkar P, Vassallo O, Falconi M, Linder S, Desideri A (2013) A natural anticancer agent thaspine targets human topoisomerase IB. Anticancer Agents Med Chem 13:356–363CrossRefPubMedGoogle Scholar
  7. Chatterjee A, Cutler SJ, Khan IA, Williamson JS (2014) Efficient synthesis of 4-oxo-4,5-dihydrothieno[3,2- c]quinoline-2-carboxylic acid derivatives from aniline. Mol Divers 18:51–59CrossRefPubMedGoogle Scholar
  8. Chauthe SK, Bharate SB, Periyasamy G, Khanna A, Bhutani KK, Mishra PD, Singh IP (2012) One pot synthesis and anticancer activity of dimeric phloroglucinols. Bioorg Med Chem Lett 22:2251–2256CrossRefPubMedGoogle Scholar
  9. Ghorab MM, Ragab FA, Heiba HI, Ghorab WM (2011) Design and synthesis of some novel quinoline derivatives as anticancer and radiosensitizing agents targeting VEGFR tyrosine kinase. J Heterocycl Chem 48:1269–1279CrossRefGoogle Scholar
  10. González-Ruiz V, Pascua I, Fernández-Marcelo T, Ribelles P, Bianchini G, Sridharan V, Iniesta P, Ramos MT, Olives AI, Martín MA, Menéndez JC (2014) B-ring-aryl substituted luotonin a analogues with a new binding mode to the topoisomerase 1-DNA complex show enhanced cytotoxic activity. PLoS ONE 9(5):e95998. doi: 10.1371/journal.pone.0095998 CrossRefPubMedCentralPubMedGoogle Scholar
  11. Guerrant W, Patil V, Canzoneri JC, Oyelere AK (2012) Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors. J Med Chem 55:1465–1477CrossRefPubMedCentralPubMedGoogle Scholar
  12. Heiniger B, Gakhar G, Prasain K, Hua DH, Nguyen TA (2010) Second-generation substituted quinolines as anticancer drugs for breast cancer. Anticancer Res 30:3927–3932PubMedGoogle Scholar
  13. Ivachtchenko AV, Khvat AV, Kobak VV, Kysil VM, Williams CT (2004) A facile synthesis of 6-sulfamoylquinoline-4-carboxylic acids. Tetrahedron Lett 45:5473–5476CrossRefGoogle Scholar
  14. Kaila N, Janz K, Huang A, Moretto A, DeBernardo S, Bedard PW, Tam S, Clerin V, Keith JC Jr, Tsao DHH, Sushkova N, Shaw GD, Camphausen RT, Schaub RG, Wang Q (2007) 2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic Acid: identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists. J Med Chem 50:40–64CrossRefPubMedGoogle Scholar
  15. Kamal A, Tamboli JR, Vishnuvardhan MVPS, Adil SF, Nayak VL, Ramakrishna S (2013) Synthesis and anticancer activity of heteroaromatic linked 4β-amido podophyllotoxins as apoptotic inducing agents. Bioorg Med Chem Lett 23:273–280CrossRefPubMedGoogle Scholar
  16. Ketron AC, Osheroff N (2014) Phytochemicals as anticancer and chemopreventive topoisomerase II poisons. Phytochem Rev 13:19–35CrossRefPubMedGoogle Scholar
  17. Khouzani HL, Sadeghi MM, Safari J, Minaeifar A (2001) A novel method for the synthesis of 2-ketomethylquinolines under solvent-free conditions using microwave irradiation. Tetrahedron Lett 42:4363–4364CrossRefGoogle Scholar
  18. Kumar D, Kumar NM, Chang KH, Shah K (2010) Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem 45:4664–4668CrossRefPubMedGoogle Scholar
  19. Lemke TL, Williams DA, Roche VF, Zito SW (2008) Foye’s principles of medicinal chemistry, 6th edn. Wolters Kluwer/Lippincott Williams & Wilkins, BaltimoreGoogle Scholar
  20. Li GX, Liu ZQ, Luo XY (2010a) Dichloro-4-quinolinol-3-carboxylic acid: Synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA. Eur J Med Chem 45:1821–1827CrossRefPubMedGoogle Scholar
  21. Li M, Miao ZH, Chen Z, Chen Q, Gui M, Lin LP, Sun P, Yi YH, Ding J (2010b) Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase2α by unique interference with its DNA binding and catalytic cycle. Ann Oncol 21:597–607CrossRefPubMedGoogle Scholar
  22. Lv PC, Li HQ, Sun J, Zhou Y, Zhu HL (2010) Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorg Med Chem 18:4606–4614CrossRefPubMedGoogle Scholar
  23. Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z (2004) Measurement of Apoptosis by DNA Fragmentation. In: Brady HJM (eds) Apoptosis methods and protocol, Humana Press Inc., Totowa, 282:1–17Google Scholar
  24. Mugnaini C, Pasquini S, Corelli F (2009) The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry. Curr Med Chem 16:1746–1767CrossRefPubMedGoogle Scholar
  25. Pilati P, Nitti D, Mocellin S (2012) Cancer Resistance to Type II Topoisomerase Inhibitors. Curr Med Chem 19:3900–3906CrossRefPubMedGoogle Scholar
  26. Ramana PV, Reddy AR (2011) Synthesis of dihydrooxazoylarylisoxazoles by conventional and under microwave conditions. Eur J Chem 2:300–307CrossRefGoogle Scholar
  27. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR (1988) Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines. Cancer Res 48:4827–4833PubMedGoogle Scholar
  28. Shanab K, Schirmer E, Wulz E, Weissenbacher B, Lassnig S, Slanz R, Fosleitner G, Holzer W, Spreitzer H, Schmidt P, Aicher B, Müller G, Gunther E (2011) Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinonepyrrolo-annelated derivatives: Part II. Bioorg Med Chem Lett 21:3117–3121CrossRefPubMedGoogle Scholar
  29. Shi ZB, Zhang L, Bin ZY, Cao XR, Gong ZN, Li JX (2013) Design, synthesis and evaluation of quinoline-based small molecule inhibitor of STAT3. Lett Drug Design Discov 10:420–426CrossRefGoogle Scholar
  30. Sikora E, Żmijewska AB, Magalska A, Piwocka K, Mosieniak G, Kalinowska M, Widlak P, Cymerman IA, Bujnicki JM (2006) Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells. Mol Cancer Ther 5:927–934CrossRefPubMedGoogle Scholar
  31. Srivastava SK, Jha A, Agarwal SK, Mukherjee R, Burman AC (2007) Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives. Anticancer Agents Med Chem 7:685–709Google Scholar
  32. Sybyl-X 1.2 (2010), St Louis
  33. Thomas KD, Adhikari V, Telkar S, Chowdhury IH, Mahmoode R, Pal NK, Rowd G, Sumesh E (2011) Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. Eur J Med Chem 46:5283–5292CrossRefPubMedGoogle Scholar
  34. Yan H, Kerns JK, Jin Q, Zhu C, Barnette MS, Callahan JF, Hay DWP, Jolivette LJ, Luttmann MA, Sarau HM, Ward KW, Widdowson KL, Wan Z (2005) A highly convergent synthesis of 2‐phenyl quinoline as dual antagonists for NK2 and NK3 receptors. Synth Commun 35:3105–3112Google Scholar
  35. Yoon H, Kim TW, Shin SY, Park MJ, Yong Y, Kim DW, Islam T, Lee YH, Jung KY, Lim Y (2013) Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells. Bioorg Med Chem Lett 23:232–238CrossRefPubMedGoogle Scholar
  36. Zembower DE, Xie Y, Koohang A, Kuffel MJ, Ames MM, Zhou Y, Mishra R, Mar A, Flavin MT, Xu ZQ (2012) Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase i inhibitors and antitumor agents. Anticancer Agents Med Chem 12:1117–1131CrossRefPubMedGoogle Scholar
  37. Zhang D, Wang G, Zhao G, Xu W, Huo L (2011) Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives. Eur J Med Chem 46:5868–5877CrossRefPubMedGoogle Scholar
  38. Zishiri VK, Joshi MC, Hunter R, Chibale K, Smith PJ, Summers RL, Martin RE, Egan TJ (2011) Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT). J Med Chem 54:6956–6968CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Hardik G. Bhatt
    • 1
    Email author
  • Yadvendra K. Agrawal
    • 2
  • Manish J. Patel
    • 3
  1. 1.Department of Pharmaceutical Chemistry, Institute of PharmacyNirma UniversityAhmedabadIndia
  2. 2.Institute of Research and DevelopmentGujarat Forensic Sciences UniversityGandhinagarIndia
  3. 3.S. K. Patel College of Pharmaceutical Education & ResearchMehsanaIndia

Personalised recommendations